EPIVACS
Diana AlessandroEpidémiologie, Prévention, Immunité et Vaccins en Suisse Epidemiologie, Prävention, Immunität und Impfstoffe in der Schweiz Epidemiology, Prevention, Immunity and Vaccines in Switzerland
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 82 | Subscribers | Read | dianaalessandro.substack.com |
Curious about how many subscribers EPIVACS has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #102 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
The Swiss Vaccine-Hesitancy Summit in spring 2026
"We are thrilled to announce the inaugural Swiss Vaccine-Hesitancy Summit, scheduled to take place in Switzerland in Spring 2026, with Luzern as the probable location.
Analyse Approfondie de la Fermeture de Mesvaccins.ch : À la Quête de Réponses Éclairées
Ce post fait appel aux journalistes d’investigation!
Beyfortus® enregistré en Suisse et disponible pour l'automne 2024-2025: vaccin ou médicament?
Le Beyfortus® (niservimab) est un anticorps monoclonal. Par définition, il ne s’agit pas d’un vaccin, mais bel et bien d’un médicament!
Le schéma de rattrapage avec le Bexsero® pour les 12-23 mois
Une fillette de 12 mois devrait-elle recevoir 2 ou 3 doses de Bexsero®?
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Pédiatre et chargé d'enseignement intéressé à la pédagogie médicale
Frequently Asked Questions
How can I access the email archive for EPIVACS?
You can find recent issues that have been published by EPIVACS on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does EPIVACS have?
To see how many people subscribe to EPIVACS, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in EPIVACS?
Newsletter advertising can be extremely effective when it's done right. Before you pitch EPIVACS as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like EPIVACS?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact EPIVACS using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to EPIVACS?
Scroll up to where it says Similar Newsletters to see other publications like EPIVACS. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact EPIVACS?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.